NCT06803680 - A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 18, 2025

Primary Completion Date

October 30, 2027

Study Completion Date

October 30, 2027

Conditions

Advanced Solid TumorMetastatic Solid Tumor

Interventions

DRUG

BGB-B455

Planned doses administered on specified days per protocol.

DRUG

Chemotherapy

Administered in accordance with relevant local guidelines and/or prescribing information.

Trial Locations (13)

78758

RECRUITING

Next Oncology, Austin

100142

RECRUITING

Beijing Cancer Hospital, Beijing

201321

RECRUITING

Fudan University Shanghai Cancer Centerpudong, Shanghai

330006

RECRUITING

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang

510060

RECRUITING

Sun Yat Sen University Cancer Center, Guangzhou

34747-4606

RECRUITING

Adventhealth, Celebration

32746-2115

RECRUITING

Florida Cancer Specialists and Research Institute, Lake Mary

19107-4307

RECRUITING

Sidney Kimmel Cancer Center, Philadelphia

57105-2108

RECRUITING

Avera Cancer Institute, Sioux Falls

NSW 2148

RECRUITING

Blacktown Cancer and Haematology Centre, Blacktown

NSW 2170

RECRUITING

Liverpool Hospital, Liverpool

QLD 4101

RECRUITING

Mater Cancer Care Centre, South Brisbane

030013

RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan